DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 04 · Volume 32 · June 2006 DOI: 10.1055/s-002-4999 Part 2: Essential Thrombocythemia and Polycythemia Vera: Diagnosis, Pathophysiology, and Management Jan J Michiels M.D. Ph.D. Martin Griesshammer M.D. Ph.D.


Villeval, Jean-Luc; James, Chloé; Pisani, Didier F.; Casadevall, Nicole; Vainchenker, William: New Insights into the Pathogenesis of JAK2 V617F-Positive Myeloproliferative Disorders and Consequences for the Management of Patients
Thiele, Juergen; Kvasnicka, Hans Michael; Schmitt-Graeff, Annette: Effects of Anagrelide on Megakaryopoiesis and Platelet Production
Quintás-Cardama, Alfonso; Kantarjian, Hagop M.; Giles, Francis; Verstovsek, Srdan: Pegylated Interferon Therapy for Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders
Kiladjian, Jean-Jacques; Rain, Jean-Didier; Bernard, Jean-Francois; Briere, Jean; Chomienne, Christine; Fenaux, Pierre: Long-Term Incidence of Hematological Evolution in Three French Prospective Studies of Hydroxyurea and Pipobroman in Polycythemia Vera and Essential Thrombocythemia